Clinical Trial Update: Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease. [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety and tolerability of tozadenant as adjunctive therapy in levodopa-treated patients with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Tozadenant (tozadenant)

Snippet

Sponsor: Biotie Therapies Inc. | Conditions: Idiopathic Parkinson Disease | Phase 3 | Status: TERMINATED | Results posted: 2019-05-03